Evidence map›Paper›PMID 28534071›Full record

ArticleHistochemistry and cell biology2017

Cloning of Helicobacter suis cholesterol α-glucosyltransferase and production of an antibody capable of detecting it in formalin-fixed, paraffin-embedded gastric tissue sections.

Masatomo Kawakubo, Kazuki Horiuchi, Hitomi Komura, Yoshiko Sato, Masayoshi Kato, Meguru Ikeyama, Mana Fukushima, Shigenori Yamada, Satoshi Ishizone, Takehisa Matsumoto and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Histochemistry and cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Cholestenone functions as an antibiotic againstProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Masatomo KawakuboDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan.
Kazuki HoriuchiDepartment of Laboratory Medicine, Shinshu University Hospital, Matsumoto, 390-8621, Japan.
Hitomi KomuraDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan.
Yoshiko SatoDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan.
Masayoshi KatoDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan.
Meguru IkeyamaDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan.
Mana FukushimaDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan.
Shigenori YamadaDivision of Gastroenterology, Iiyama Red Cross Hospital, Iiyama, 389-2295, Japan.
Satoshi IshizoneDivision of Surgery, North Alps Medical Center Azumi Hospital, Ikeda, 399-8695, Japan.
Takehisa MatsumotoDepartment of Laboratory Medicine, Shinshu University Hospital, Matsumoto, 390-8621, Japan.
Hiroyoshi OtaDepartment of Biomedical Laboratory Science, School of Health Sciences, Shinshu University, Matsumoto, 390-8621, Japan.
Junji SagaraDepartment of Biomedical Laboratory Science, School of Health Sciences, Shinshu University, Matsumoto, 390-8621, Japan.
Jun NakayamaDepartment of Molecular Pathology, Shinshu University Graduate School of Medicine, Matsumoto, 390-8621, Japan. jnaka@shinshu-u.ac.jp.
Shinshu University · JPShinshu University Hospital · JPAzumi Hospital · JPMatsuyama Red Cross Hospital · JP

Funding

Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (B) 15H04712Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (C) 16K08708
6 · The paper itself

Abstract

Helicobacter suis (H. suis), formerly called Helicobacter heilmannii type 1 (H. heilmannii), is a gram-negative bacterium of the Helicobacter species. This pathogen infects the stomach of humans and animals such as dogs, cats, pigs, and rodents, the latter giving rise to zoonotic infection. Here, we generated a H. suis-specific antibody useful for immunohistochemistry with formalin-fixed, paraffin-embedded tissue sections. To do so, we began by cloning the gene encoding H. suis cholesterol α-glucosyltransferase (αCgT). αCgT is the key enzyme responsible for biosynthesis of cholesteryl α-D-glucopyranoside (CGL), a major cell wall component of Helicobacter species including H. suis. The deduced amino acid sequence of H. suis αCgT had 56% identity with the corresponding Helicobacter pylori (H. pylori). We then developed a polyclonal antibody (anti-Hh-I205R) by immunizing rabbits with a 205 amino acid H. suis αCgT fragment. Immunohistochemistry with the anti-Hh-I205R antibody could differentiate H. suis from H. pylori in gastric mucosa sections derived from mice infected with either pathogen. We then probed formalin-fixed, paraffin-embedded sections of human gastric mucosa positive for H. suis infection with the anti-Hh-I205R antibody and detected positive staining. These results indicate that anti-Hh-I205R antibody is specific for H. suis αCgT and useful to detect H. suis in gastric specimens routinely analyzed in pathological examinations.

Indexed as

AnimalsAntibodiesCell DifferentiationCell WallCholesterolCloning, MolecularFormaldehydeGastric MucosaGlucosyltransferasesHelicobacter heilmanniiHumansImmunohistochemistryMiceParaffin EmbeddingAntibodiesCholesterolFormaldehydeGlucosyltransferasesGlycosyltransferaseHelicobacter pyloriImmunohistochemistryNon-H. pylori helicobactersZoonosis

Identifiers

PMID28534071
OpenAlexW2620164496

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.